Innovent Biologics, Inc. (IVBXF)
Innovent Biologics Market Cap : 18.96B for Nov. 16, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 16, 2026 | 18.96B |
| November 13, 2026 | 19.27B |
| November 12, 2026 | 19.23B |
| November 11, 2026 | 19.27B |
| November 10, 2026 | 19.54B |
| November 09, 2026 | 19.23B |
| November 06, 2026 | 19.29B |
| November 05, 2026 | 19.43B |
| November 04, 2026 | 19.66B |
| November 03, 2026 | 17.50B |
| November 02, 2026 | 18.31B |
| October 30, 2026 | 17.21B |
| October 29, 2026 | 19.64B |
| October 28, 2026 | 19.32B |
| October 27, 2026 | 17.56B |
| October 26, 2026 | 18.51B |
| October 23, 2026 | 20.07B |
| October 22, 2026 | 20.16B |
| October 21, 2026 | 21.23B |
| October 20, 2026 | 20.88B |
| October 19, 2026 | 21.20B |
| October 16, 2026 | 21.73B |
| October 15, 2026 | 21.73B |
| October 14, 2026 | 19.76B |
| October 13, 2026 | 19.73B |
| Date | Value |
|---|---|
| October 12, 2026 | 17.92B |
| October 09, 2026 | 21.10B |
| October 08, 2026 | 20.86B |
| October 07, 2026 | 22.25B |
| October 06, 2026 | 21.21B |
| October 05, 2026 | 21.21B |
| October 02, 2026 | 22.25B |
| October 01, 2026 | 21.75B |
| September 30, 2026 | 21.78B |
| September 29, 2026 | 23.22B |
| September 28, 2026 | 23.22B |
| September 25, 2026 | 21.65B |
| September 24, 2026 | 21.65B |
| September 23, 2026 | 21.77B |
| September 22, 2026 | 24.72B |
| September 21, 2026 | 21.73B |
| September 18, 2026 | 21.43B |
| September 17, 2026 | 21.43B |
| September 16, 2026 | 19.09B |
| September 15, 2026 | 21.40B |
| September 14, 2026 | 20.40B |
| September 11, 2026 | 20.40B |
| September 10, 2026 | 20.82B |
| September 09, 2026 | 21.96B |
| September 08, 2026 | 22.87B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Ascletis Pharma, Inc. | 659.37M |
| CStone Pharmaceuticals Co. Ltd. | 1.097B |
| RemeGen Co., Ltd. | 5.583B |
| InnoCare Pharma Ltd. | 2.828B |
| Adagene, Inc. | 107.43M |
Market Cap Related Metrics
| PE Ratio | 109.41 |
| PS Ratio | 8.568 |
| Price to Free Cash Flow | 10.52 |
| Price | 10.91 |
| Earnings Yield | 0.91% |
| Operating PE Ratio | 50.72 |
| Normalized PE Ratio | 124.24 |